Hypertension trials recruiting in Utah

All Hypertension trials nationally

Cities in Utah

Recruiting trials in Utah

• : Vascular Function in Health and Disease
  NCT02966665 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Utah: Salt Lake City
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Utah: South Salt Lake
• A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
  NCT06649110 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Utah: Salt Lake City
• A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
  NCT05201144 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · Utah: Salt Lake City
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
  NCT06129240 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · Utah: Salt Lake City
• Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)
  NCT06105242 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Utah: Murray
• De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
  NCT05213676 · Phase: Phase 4 · Ages: 0 Months to 1 Month · Sex: All (male and female) · Utah: Salt Lake City
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT06388421 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Utah: Murray, Salt Lake City
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Utah: Salt Lake City, West Jordan
• Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
  NCT06468202 · Phase: Phase 4 · Ages: 14 Years to 35 Years · Sex: Female · Utah: Salt Lake City
• Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
  NCT07090161 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Utah: Salt Lake City
• Global Paradise System US Post Approval Study
  NCT06297291 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Utah: Salt Lake City
• Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
  NCT06039176 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Utah: Salt Lake City
• Hydrus® Microstent New Enrollment Post-Approval Study
  NCT04553523 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: All (male and female) · Utah: Salt Lake City
• Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
  NCT06911632 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Utah: Salt Lake City
• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
  NCT06274801 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Utah: Murray, Salt Lake City
• Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
  NCT05826925 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Utah: Salt Lake City
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Utah: Salt Lake City
• Pulmonary Hypertension Association Registry
  NCT04071327 · Phase: Not specified · Ages: 0 Years and older · Sex: All (male and female) · Utah: Salt Lake City
• THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
  NCT06559891 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 75 Years · Sex: All (male and female) · Utah: Salt Lake City
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Utah: Salt Lake City
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Utah: Bountiful, Layton